Dextrose 5% (D5W): Clinical Trials

3 trials of Dextrose 5% (D5W), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 1 Early Phase 1, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Not applicable1Unknown 1
Phase 41Completed 1

Follow Dextrose 5% (D5W): new trials by email Literature Review of Dextrose 5% (D5W) trials Research Report on Dextrose 5% (D5W)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
Ceftriaxone (Rocephin®), Dextrose 5% (D5W) - Post-Treatment Lyme Disease
Early Phase 1RecruitingState University of New York - Upstate Medical University442025-02-032026-03-19
Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section
Tranexamic Acid (IV), Dextrose 5% (D5W) - Cesarean Section, Blood Loss During Surgery
Phase 4CompletedCombined Military Hospital Multan682023-11-012025-06-10
Delto-Tricipital Compression Syndrome: Treated With Injection of Dextrose
Dextrose 5% (D5W), Physical therapy - Superficial Radial Nerve Lesion
Not applicableUnknownUniversidad Abierta Interamericana802015-01-012015-03-17

Conditions studied

Post-Lyme Disease Syndrome (1)  ·  Radial Neuropathy (1)

Sponsors

Combined Military Hospital Multan (1)  ·  State University of New York - Upstate Medical University (1)  ·  Universidad Abierta Interamericana (1)

Countries

Argentina (1)  ·  Pakistan (1)  ·  United States (1)

Top investigators

David Rabago (1)  ·  Dean Reeves (1)  ·  Kristopher Paolino, MD (1)  ·  Mailand Ezequiel, MD (1)  ·  Nidda Y Professor, FCPS (1)

Results publications

PMID 19549615, PMID 23850615